HOME > 教室について > 業績リスト > 【発表論文】英文 > 2012年

2012年

  1. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, Shiode N, Namura M, Sone T, Oshima S, Nishikawa H, Hiasa Y, Hayashi Y, Nobuyoshi M, Mitudo K; j-Cypher Registry Investigators. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry. Circulation. 2012 Jan 31;125(4):584-91.
  2. Kimura T, Morimoto T, Natsuaki M, Shiomi H, Igarashi K, Kadota K, Tanabe K, Morino Y, Akasaka T, Takatsu Y, Nishikawa H, Yamamoto Y, Nakagawa Y, Hayashi Y, Iwabuchi M, Umeda H, Kawai K, Okada H, Kimura K, Simonton CA, Kozuma K; on behalf of the RESET Investigators. Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents: 1-Year Outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET). Circulation. 2012 Sep 4;126(10):1225-1236. Epub 2012 Jul 23.
  3. Kimura T, Morimoto T, Nakagawa Y, Kadota K, Nozaki Y, Tada T, Take S, Shirota K, Ito A, Nakashima H, Fujita H, Kawasaki T, Inada T, Nakao K, Miyazaki S, Doi O, Isshiki T, Nobuyoshi M, Mitsudo K. Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry. Cardiovasc Interv Ther. 2012 Sep;27(3):181-8. Epub 2012 Jun 14. Erratum in: Cardiovasc Interv Ther. 2013 Jan;28(1):135-6. Mitudo, Kazuaki [corrected to Mitsudo, Kazuaki].
  4. Tanaka S, Sakata R, Marui A, Furukawa Y, Kita T, Kimura T; CREDO-Kyoto Investigators. Predicting long-term mortality after first coronary revascularization: -the Kyoto model - Circ J. 2012;76(2):328-34.
  5. Marui A, Kimura T, Tanaka S, Furukawa Y, Kita T, Sakata R; CREDO-Kyoto Investigators. Significance of off-pump coronary artery bypass grafting compared with percutaneous coronary intervention: a propensity score analysis. Eur J Cardiothorac Surg. 2012 Jan;41(1):94-101.
  6. Tokushige A, Shiomi H, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Hamasaki S, Tei C, Nakashima H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T. Influence of initial acute myocardial infarction presentation on the outcome of surgical procedures after coronary stent implantation: a report from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Cardiovasc Interv Ther. 2013 Jan;28(1):45-55.
  7. Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Kimura T. Comparison of 3-year clinical outcomes after transradial versus transfemoral percutaneous coronary intervention. Cardiovasc Interv Ther. 2012 May; 27(2):84-92.
  8. Ken Kozuma, Takeshi Kimura, Nobuaki Suzuki, Akiyoshi Miyazawa, Katsuhisa Waseda, Yasuhiro Honda, Takeshi Morimoto, Tadanori Aizawa, Kazuaki Mitsudo, Shunichi Miyazaki, Tetsu Yamaguchi, Takaaki Isshiki. Peri-stent Contrast Staining and Very Late Stent Thrombosis After Sirolimus-eluting Stent Implantation: An observation from the RESTART (REgistry of Stent Thrombosis for review And Re-evaluaTion) angiographic sub-study. EuroIntervention. 2013 Feb 18. pii: 20120125-01.
  9. Sunagawa Y, Wada H, Suzuki H, Sasaki H, Imaizumi A, Fukuda H, Hashimoto T, Katanasaka Y, Shimatsu A, Kimura T, Kakeya H, Fujita M, Hasegawa K, Morimoto T.　A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in rats.　Biol Pharm Bull. 2012; 35(2):139-44.
  10. Bao B, Ozasa N, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Natsuaki M, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T. Beta-blocker Therapy and Cardiovascular Outcomes in Patients Who Have Undergone Percutaneous Coronary Intervention After ST-elevation Myocardial Infarction. Cardiovasc Interv Ther. 2013 Apr;28(2):139-47.
  11. Hiroaki Takashima, Yukio Ozaki, Takeshi Morimoto, Takeshi Kimura, Takafumi Hiro, Katsumi Miyauchi, Yoshihisa Nakagawa, Masakazu Yamagishi, Hiroyuki Daida, Tomofumi Mizuno, Kenji Asai, Yasuo Kuroda, Takashi Kosaka, Yasushi Kuhara, Akiyoshi Kurita, Kazuyuki Maeda, Masunori Matsuzaki, for the JAPAN-ACS Investigators. Clustering of Metabolic Syndrome Components Attenuates Coronary Plaque Regression During Intensive Statin Therapy in Patients With Acute Coronary Syndrome - Serial Intravascular Ultrasound Analysis from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (JAPAN-ACS Trial) – Circ J. 2012;76(12):2840-7. Epub 2012 Sep 7.
  12. Saito R, Shirakawa R, Nishiyama H, Kobayashi T, Kawato M, Kanno T, Nishizawa K, Matsui Y, Ohbayashi T, Horiguchi M, Nakamura T, Ikeda T, Yamane K, Nakayama E, Nakamura E, Toda Y, Kimura T, Kita T, Ogawa O, Horiuchi H. Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer. Oncogene. 2012 Mar 26.
  13. Kohsaka S, Goto M, Nagai T, Lee VV, Elayda M, Furukawa Y, Fukushima M, Komeda M, Sakata R, Ohsugi M, Fukuda K, Wilson JM, Kita T, Kimura T. Impact of diabetes among revascularized patients in Japan and the U.S. Diabetes Care. 2012 Mar; 35(3):654-9. Epub 2012 Feb 1.
  14. Miyata H, Uno K, Ono T, Yashiro M, Fukatsu A, Kita T, Kimura T, Muso E. Low density lipoprotein apheresis ameliorates interferon-ﾎｳ production in patients with nephrotic syndrome. Ther Apher Dial. 2012 Apr; 16(2):189-94.
  15. Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, Inada T, Mitsuoka H, Taniguchi R, Nakano A, Kita T, Sakata R, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2. Circ J. 2012;76(6):1369-79. Epub 2012 Mar 15.
  16. Yamane K, Ikeda T, Taniguchi R, Watanabe S, Kawato M, Kondo H, Shirakawa R, Higashi T, Toma M, Tabuchi A, Tamura T, Takahashi K, Watanabe H, Yoshikawa Y, Kita T, Kimura T, Horiuchi H. Impact of platelet reactivity on long-term clinical outcomes and bleeding events in Japanese patients receiving antiplatelet therapy with aspirin. J Atheroscler Thromb. 2012;19(12):1142-53. Epub 2012 Aug 9.
  17. Hattori T, Makiyama T, Akao M, Ehara E, Ohno S, Iguchi M, Nishio Y, Sasaki K, Itoh H, Yokode M, Kita T, Horie M, Kimura T. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents. Cardiovasc Res. 2012 Mar 15;93(4): 159-73.
  18. Niizuma S, Inuzuka Y, Okuda J, Kato T, Kawashima T, Tamaki Y, Iwanaga Y, Yoshida Y, Kosugi R, Watanabe-Maeda K, Machida Y, Tsuji S, Aburatani H, Izumi T, Kita T, Kimura T, Shioi T. Effect of persistent activation of phosphoinositide 3-kinase on heart. Life Sci. 2012 Apr 20; 90(15-16):619-28.
  19. Kanda K, Komekado H, Sawabu T, Ishizu S, Nakanishi Y, Nakatsuji M, Akitake-Kawano R, Ohno M, Hiraoka Y, Kawada M, Kawada K, Sakai Y, Matsumoto K, Kunichika M, Kimura T, Seno H, Nishi E, Chiba T. Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α. EMBO Mol Med. 2012 May;4(5):396-411.
  20. Natsuaki M, Nakagawa Y, Morimoto T, Ono K, Shizuta S, Furukawa Y, Kadota K, Iwabuchi M, Kato Y, Suwa S, Inada T, Doi O, Takizawa A, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Impact of statin therapy on late target lesion revascularization after sirolimus-eluting stent implantation (from the CREDO-Kyoto Registry Cohort-2). Am J Cardiol. 2012 May 15;109(10):1387-96. Epub 2012 Feb 28.
  21. Tada T, Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Byrne RA, Kastrati A, Kadota K, Iwabuchi M, Shizuta S, Tazaki J, Shiomi H, Abe M, Ehara N, Mizoguchi T, Mitsuoka H, Inada T, Araki M, Kaburagi S, Taniguchi R, Eizawa H, Nakano A, et al. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Circ Cardiovasc Interv. 2012 Jun;5(3):381-91.
  22. Iguchi M, Kato M, Nakai J, Takeda T, Matsumoto-Ida M, Kita T, Kimura T, Akao M. Direct monitoring of mitochondrial calcium levels in cultured cardiac myocytes using a novel fluorescent indicator protein, GCaMP2-mt. Int J Cardiol. 2012 Jul 12;158(2):225-34.
  23. Kato M, Kimura T, Morimoto T, Nishikawa H, Uchida F, Suzuki H, Hayashi Y, Kadota K, Mitsudo K; J-Cypher Registry Investigators. Comparison of Five-Year Outcome of Sirolimus-Eluting Stent Implantation for Chronic Total Occlusions Versus for Non-Chronic Total Occlusion (from the j-Cypher Registry). Am J Cardiol. 2012 Jul 24.
  24. Marui A, Okabayashi H, Komiya T, Tanaka S, Furukawa Y, Kita T, Kimura T, Sakata R; CREDO-Kyoto Investigators. Benefits of off-pump coronary artery bypass grafting in high-risk patients. Circulation. 2012 Sep 11;126(11 Suppl 1):S151-7.
  25. Marui A, Kimura T, Tanaka S, Okabayashi H, Komiya T, Furukawa Y, Kita T, Sakata R; CREDO-Kyoto Investigators. Comparison of Frequency of Postoperative Stroke in Off-Pump Coronary Artery Bypass Grafting Versus On-Pump Coron ary Artery Bypass Grafting Versus Percutaneous Coronary Intervention. Am J Cardiol. 2012 Sep 12.
  26. Nakao T, Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Nobuyoshi M, Kita T, Mitsudo K. The long-term efficacy of cilostazol in addition to dual antiplatelet therapy after sirolimus-eluting stent implantation for Japanese patients: an analysis of the 3-year follow-up outcomes from the j-Cypher registry. Cardiovasc Interv Ther. 2012 Sep;27(3):161-7. Epub 2012 May 26.
  27. Hamatani Y, Saito N, Tazaki J, Natsuaki M, Nakai K, Makiyama T, Sasaki Y, Imai M, Watanabe S, Shioi T, Kimura T, Inoue K. Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis. Heart Vessels. 2012 Nov 22. [Epub ahead of print]
  28. Marui A, Kimura T, Tanaka S, Okabayashi H, Komiya T, Furukawa Y, Kita T, Sakata R; CREDO-Kyoto Investigators. Comparison of frequency of postoperative stroke in off-pump coronary artery bypass grafting versus on-pump coronary artery bypass grafting versus percutaneous coronary intervention. Am J Cardiol. 2012 Dec 15;110(12):1773-8. doi: 10.1016/j.amjcard.2012.08.010. Epub 2012 Sep 13.
  29. Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K, Origasa H, Morino Y, Tsutsui H,Kobayashi M, Isshiki T; PACIFIC investigators. Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention ofatherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J. 2013;77(4):934-43. Epub 2013 Mar 15.
  30. Nakamura M, Yamagishi M, Ueno T, Hara K, Ishiwata S, Itoh T, Hamanaka I, Wakatsuki T, Sugano T, Kawai K, Kimura T. Current treatment of ST elevation acute myocardial infarction in Japan: door-to-balloon time and total ischemictime from the J-AMI registry. Cardiovasc Interv Ther. 2013 Jan;28(1):30-6. doi: 10.1007/s12928-012-0128-x. Epub 2012 Sep 16.
  31. Okumura Ken, Aizawa Yoshifusa, Aonuma Kazutaka, Hagiwara Nobuhisa, Isobe Fumitaka, Katoh Takao, Matsumoto Kazuo, Murakawa Yuji, Nitta Takashi, Ohnishi Satoshi, Shimizu Akihiko, Hirao Kenzo, Ishikawa Toshiyuki, Iwa Toru, Kurita Takashi, Kusano Kengo, Nakamura Yoshihide, Nakazato Yuji, Niwano Shinichi, Sasaki Shingo, Shiga Tsuyoshi, Shoda Morio, Sumitomo Naokata, Umemura Jun, Kasanuki Hiroshi, Kimura Takeshi, Kodama Itsuo, Ohe Tohru, Tanaka Shigeo, JCS joint Working Group Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011). Circ J. 2013;77(1):249-74. Epub 2012 Nov 17.
  32. Takashima H, Ozaki Y, Morimoto T, Kimura T, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Daida H, Mizuno T, Asai K, Kuroda Y, Kosaka T, Kuhara Y, Kurita A, Maeda K, Amano T, Matsuzaki M; JAPAN-ACS Investigators. Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statintherapy in patients with acute coronary syndrome: the JAPAN-ACS subanalysis study. Circ J. 2012;76(12):2840-7. Epub 2012 Sep 7.
  33. Yamauchi T, Tamaki N, Kasanuki H, Kimura T, Uemura Y, Iimuro S; Japanese Coronary-Angiography or Myocardial Imaging for Angina Pectoris Study (J-COMPASS) Multicenter Study Group. Optimal initial diagnostic strategies for the evaluation of stable angina patients: a multicenter, prospective studyon myocardial perfusion imaging, computed tomographic angiography, and coronary angiography. Circ J. 2012;76(12):2832-9. Epub 2012 Aug 28.
  34. Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, Chen J, Hattori T, Ohno S, Kita T, Horie M, Yamanaka S, Kimura T. Ultrastructural Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Long-Term Culture. Circ J. 2013 Feb 9.
  35. Villafañe J, Atallah J, Gollob MH, Maury P, Wolpert C, Gebauer R, Watanabe H, Horie M, Anttonen O, Kannankeril P, Faulknier B, Bleiz J, Makiyama T, Shimizu W, Hamilton R, Young ML. Long-Term Follow-Up of a Pediatric Cohort With Short QT Syndrome. J Am Coll Cardiol. 2013 Jan 25.
  36. Ishikawa T, Takahashi N, Ohno S, Sakurada H, Nakamura K, On YK, Park JE, Makiyama T, Horie M, Arimura T, Makita N, Kimura A. Novel SCN3B Mutation Associated With Brugada Syndrome Affects Intracellular Trafficking and Function of Nav1.5. Circ J. 2012 Dec 21.
  37. Hattori T, Makiyama T, Akao M, Ehara E, Ohno S, Iguchi M, Nishio Y, Sasaki K, Itoh H, Yokode M, Kita T, Horie M, Kimura T. A novel gain-of-function KCNJ2 mutation associated with short QT syndrome impairs inward rectification of Kir2.1 currents. Cardiovasc Res. 2012 Mar 15;93(4):666-73.
  38. Kimura H, Zhou J, Kawamura M, Itoh H, Mizusawa Y, Ding WG, Wu J, Ohno S, Makiyama T, Miyamoto A, Naiki N, Wang Q, Xie Y, Suzuki T, Tateno S, Nakamura Y, Zang WJ, Ito M, Matsuura H, Horie M. Phenotype variability in patients carrying KCNJ2 mutations. Circ Cardiovasc Genet. 2012 Jun;5(3):344-53.
  39. Watanabe H, Nogami A, Ohkubo K, Kawata H, Hayashi Y, Ishikawa T, Makiyama T, Nagao S, Yagihara N, Takehara N, Kawamura Y, Sato A, Okamura K, Hosaka Y, Sato M, Fukae S, Chinushi M, Oda H, Okabe M, Kimura A, Maemura K, Watanabe I, Kamakura S, Horie M, Aizawa Y, Shimizu W, Makita N. Clinical characteristics and risk of arrhythmia recurrences in patients with idiopathic ventricular fibrillation associated with early repolarization. Int J Cardiol. 2012 Sep 6;159(3):238-40.
  40. Imai S, Matsuda M, Fukui M, Hasegawa G, Ozasa N, Miyake M, Komatsu T, Kajiyama S. Gender-Dependent effect of AGT m235T polymorphisms on glycated hemoglobin in Japanese females with type 2 diabetes. J of Life Sci Res. 2011; 9:1-5..
  41. Hamatani Y, Saito N, Tazaki J, Natsuaki M, Nakai K, Makiyama T, Sasaki Y, Imai M, Watanabe S, Shioi T, Kimura T, Inoue K.Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis. Heart Vessels. 2012 Nov 22.
  42. Yamane K, Kato Y, Tazaki J, Tada T, Makiyama T, Imai M, Jinnai T, Ikeda T, Shirakawa R, Kimura T, Horiuchi H.Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy. J Atheroscler Thromb. 2012;19(6):559-69.
  43. Shiomi H, Tamura T, Niki S, Tada T, Tazaki J, Toma M, Ono K, Shioi T, Morimoto T, Akao M, Furukawa Y, Nakagawa Y, Kimura T.　Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world. Circ J. 2011 Apr 25;75(5):1130-7. Epub 2011 Mar 30.
  44. Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Akao M, Ono K, Shioi T, Shizuta S, Sakata R, Okabayashi H, Nishiwaki N, Komiya T, Suwa S, Kimura T.Impact of diabetes on cardiovascular outcomes in hemodialysis patients undergoing coronary revascularization.　Circulation Journal 2011;75(7):1616-25.
  45. Masahiro Natsuaki, Yutaka Furukawa, Takeshi Morimoto, Yoshihisa Nakagawa, Masaharu Akao, Koh Ono, Tetsuo Shioi, Satoshi Shizuta, Ryuzo Sakata, Hitoshi Okabayashi, Noboru Nishiwaki, Tatsuhiko Komiya, Satoru Suwa, Takeshi Kimura. Impact of diabetes on cardiovascular outcomes in hemodialysis patients undergoing coronary revascularization. Circ J. 2011 Jun 24;75(7):1616-25.
  46. Tazaki J, Jinnai T, Tada T, Kato Y, Makiyama T, Ikeda T, Yamane K, Naruse Y, Takahashi K, Watanabe H, Kimura T, Horiuchi H. Prediction of Clopidogrel Low Responders by a Rapid CYP2C19 Activity Test. J Atheroscler Thromb. 2011 Dec.14. 186-93.
  47. Shiomi H, Morimoto T, Hayano M, Furukawa Y, Nakagawa Y, Tazaki J, Imai M, Yamaji K, Tada T, Natsuaki M, Saijo S, Funakoshi S, Nagao K, Hanazawa K, Ehara N, Kadota K, Iwabuchi M, Shizuta S, Abe M, Sakata R, Okabayashi H, Hanyu M, Yamazaki F, Shimamoto M, Nishiwaki N, Imoto Y, Komiya T, Horie M, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T. CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary arterydisease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2012 Oct 1;110(7):924-32.
  48. Kawaji T, Shiomi H, Togashi Y, Gunji D, Imai M, Doi T, Kimura T. Coronary air embolism and cardiogenic shock during computed tomography-guided needle biopsy of the lung. Circulation. 2012 Sep 25;126(13):e195-7.
  49. Tada T, Kadota K, Hosogi S, Kubo S, Ozaki M, Yoshino M, Miyake K, Eguchi H, Ohashi N, Hayakawa Y, Saito N, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Imai M, Tanaka H, Fuku Y, Oka N, Kato H, Yamamoto H, Fujii S, Goto T, Mitsudo K. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining. CircCardiovascInterv.2012Oct;5(5):649-56.
  50. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, Watanabe S, Baba O, Kojima Y, Shizuta S, Imai M, Tamura T, Kita T, Kimura T. Increased microRNA-1 and microRNA-133a Levels in Serum of Patients with Cardiovascular Disease Indicate the Existence of Myocardial Damage. Circ Cardiovasc Genet. 2011 Jun 2.
  51. Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, Fuku Y, Hosogi S, Hirono A, Tanaka H, Tada T, Morimoto T, Shiomi H, Kozuma K, Inoue K, Suzuki N, Kimura T, Mitsudo K. Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation. 2011 May 31;123(21):2382-91.
  52. Imai S, Matsuda M, Hasegawa G, Fukui M, Obayashi H, Ozasa N, Kajiyama S. Simple meal plan of ‘eating vegetables before carbohydrate’ was more effective for achieving glycemic control than an exchange–based meal plan in Japanese patients with type 2 diabetes. Asia Pac J Clin Nutr 2011;20(2):161-8.
  53. Kishimoto C, Nimata M, Okabe T, Shioji K: Immunoglobulin treatment ameliorates myocardial injury in experimental autoimmune myocarditis associated with suppression of reactive oxygen species. Int J Cardiol 167: 140-145, 2013.
  54. Tamaki Y, Iwanaga Y, Niizuma S, Kawashima T, Kato T, Inuzuka Y, Horie T, Morooka H, Takase T, Akahashi Y, Kobuke K, Ono K, Shioi T, Sheikh SP, Ambartsumian N, Lukanidin E, Koshimizu TA, Miyazaki S, Kimura T. Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts. J Mol Cell Cardiol. 2013;57:72-81.
  55. Tokushige A, Shiomi H, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Hamasaki S, Tei C, Nakashima H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T. Influence of initial acute myocardial infarction presentation on the outcome of surgical procedures after coronary stent implantation: a report from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Cardiovasc Interv Ther. 2013 ;28:45-55.
  56. Horie T, Baba O, Kuwabara Y, Chujo Y, Watanabe S, Kinoshita M, Horiguchi M, Nakamura T, Chonabayashi K, Hishizawa M, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, Ono K. MicroRNA-33-deficiency reduces the progression of atherosclerotic plaque in apoE-/- mice. J Am Heart Assoc. 2012;1:e003376.
  57. Ono K, Current concept of reverse cholesterol transport and novel strategy for atheroprotection. J Cardiol. 2012 ;60:339-43.
  58. Takaya T, Nishi H, Horie T, Ono K, Hasegawa K. Roles of MicroRNAs and Myocardial Cell Differentiation. Prog Mol Biol Transl Sci. 2012;111:139-52.
  59. Satoh-Asahara N, Shimatsu A, Sasaki Y, Nakaoka H, Himeno A, Tochiya M, Kono S, Takaya T, Ono K, Wada H, Suganami T, Hasegawa K, Ogawa Y. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care. 2012;35:2631-9.
  60. Ogura C, Ono K, Miyamoto S, Ikai A, Mitani S, Sugimoto N, Tanaka S, Fujita M. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension. Blood Press. 2012; 21:367-71.
  61. Sowa N, Horie T, Kuwabara Y, Baba O, Watanabe S, Nishi H, Kinoshita M, Takanabe-Mori R, Wada H, Shimatsu A, Hasegawa K, Kimura T, and Ono K. MicroRNA 26b Encoded by the Intron of Small CTD Phosphatase (SCP) 1 Has an Antagonistic Effect on its Host Gene. Journal of Cellular Biochem. 2012 ;113:3455-65.
  62. Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, Inada T, Mitsuoka H, Taniguchi R, Nakano A, Kita T, Sakata R, Kimura T; on behalf of the CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Intensity of Statin Therapy, Achieved LDL-C Levels and Cardiovascular Outcomes in Japanese Patients After Coronary Revascularization. Circ J. 2012; 76:1369-1379.
  63. Natsuaki M, Nakagawa Y, Morimoto T, Ono K, Shizuta S, Furukawa Y, Kadota K, Iwabuchi M, Kato Y, Suwa S, Inada T, Doi O, Takizawa A, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Impact of Statin Therapy on Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (from the CREDO-Kyoto Registry Cohort-2). Am J Cardiol. 2012; 109:1387-96.
  64. Wada H, Ura S, Satoh-Asahara N, Kitaoka S, Mashiba S, Akao M, Abe M, Ono K, Morimoto T, Fujita M, Shimatsu A, Takahashi Y, Hasegawa K. α1-Antitrypsin-low-density-lipoprotein Serves as a Marker of Smoking-specific Oxidative Stress. J Atheroscler Thromb 2012;19:47-58.
  65. Shimada K, Hirano E, Kimura T, Fujita M, Kishimoto C: Carvedilol reduces the severity of atherosclerosis in apolipoprotein E-deficient mice via reducing superoxide production. Exp Biol Med 237: 1039-1044, 2012.
  66. Yuan Z, Wang X, Liu X, Kishimoto C: The role of Fcγ receptors in atherosclerosis. Exp Biol Med 237: 609-616, 2012.
  67. Tomohide Takaya, Hitoo Nishi, Takahiro Horie, Koh Ono, and Koji Hasegawa, Roles of MicroRNAs and Myocardial Cell Differentiation. In Yaoliang Tang, editor: Progress in Molecular Biology and Translational Science, Vol. 111, Burlington: Academic Press, 2012, pp. 139-152.
  68. Hirano E, Shimada K, Komiyama T, Fujita M, Kishimoto C: Erythromycin treatment suppresses myocardial injury in autoimmune myocarditis in rats via suppression of superoxide production. Int J Cardiol: 167: 2228-2233, 2013.
  69. Kishimoto C, Shioji K, Hashimoto T, Nonogi H, Lee JD, Kato S, Hiramatsu S, Morimoto S: Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy. Analysis of leukocyte balance. Heart & Vessels [Epub ahead of print] 2013, May 24.
  70. Kishimoto C, Tamaru K, Kuwahara H: Tall P waves associated with severe hypokalemia and combined electrolyte depletion. J Electrocardiol 2013 oct.4.doi:pii:S0022-0736(13)00431-7.10.1016/j.jelectrocard.2013.09.002. [Epub ahead of print]
  71. Tamaki Y, Iwanaga Y, Niizuma S, Kawashima T, Kato T, Inuzuka Y, Horie T, Morooka H, Takase T, Akahashi Y, Kobuke K, Ono K, Shioi T, Sheikh SP, Ambartsumian N, Lukanidin E, Koshimizu TA, Miyazaki S, Kimura T. Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts. J Mol Cell Cardiol. 57, 72-81, 2013.
  72. Shioi T, Inuzuka Y. Aging as a substrate of heart failure. J Cardiol. 60, 423-8, 2012.
  73. Nishi E. Nardilysin (MS: 328) The Handbook of Proteolytic Enzymes (The 3rd Edition), 20 Dec 2012 Edited by Neil D. Rawlings and Guy Salvesen Academic Press.
  74. Kanda K, Komekado H, Sawabu T, Ishizu S, Nakanishi Y, Nakatsuji M, Akitake-Kawano R, Ohno M, Hiraoka Y, Kawada M, Kawada K, Sakai Y, Matsumoto K, Kunichika M, Kimura T, Seno H*, Nishi E*, and ChibaT (*Co-corresponding author) Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signaling via enhanced ectodomain shedding of TNF-a EMBO. Mol Med, 4:396-411, 2012.
  75. Naritatsu Saito, Fumiaki Ikeno. "Large Animal Models of Human Cardiovascular Disease " , Animal Models in Cancer Research and Human Disease: Applications, Outcomes and Controversies, Nova Publishers.
  76. Shiomi H, Toyofuku M, Kimura T. Current status of unprotected left main coronary stenting with first-generation drug-eluting stents: insight from j-Cypher registry. J Jpn Coron Assoc 2011; 17:264-268.
  77. Watanabe S, Saito N, Tokushige A, Bingyuan B, Kawase Y, Kimura T: A novel method to deliver the filtrap coronary embolic protection filter using a manual thrombectomy catheter: in vitro and in vivo comparison with the conventional method. J Invasive Cardiol. 24:159–63. 2012
  78. Bao, B, Saito, N, Watanabe, S, Tokushige, A, Yamamoto, E, Kawase, Y, Kimura, T, Inoue, K. A novel device for antegrade percutaneous balloon aortic valvuloplasty: Feasibility of the looped inoue balloon technique in swine model. Catheter Cardiovasc Interv: [Epub ahead of print]; 2013 Mar 4.
  79. Naritatsu Saito, Fumiaki Ikeno: Large Animal Models of Human Cardiovascular Disease, Animal Models in Cancer Research and Human Disease: Applications, Outcomes and Controversies. Nova Publishers, 47-67. 2013
  80. Hamatani, Y, Saito, N, Tazaki, J, Natsuaki, M, Nakai, K, Makiyama, T, Sasaki, Y, Imai, M, Watanabe, S, Shioi, T, Kimura, T, Inoue, K. Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis. Heart Vessels 2012.
  81. Watanabe, S, Saito, N, Tokushige, A, Bingyuan, B, Kawase, Y, Kimura, T. A novel method to deliver the filtrap coronary embolic protection filter using a manual thrombectomy catheter: in vitro and in vivo comparison with the conventional method. J Invasive Cardiol 2012; 24:159–63.
  82. Ozasa N, Morimoto T, Bao B, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tazaki J, Natsuaki M, Kimura T; on behalf of the CREDO-Kyoto registry investigators. β-blocker use in patients after percutaneous coronary interventions: One size fits all? Worse outcomes in patients without myocardial infarction or heart failure. Int J Cardiol. 2012 [Epub ahead of print]
  83. Ozasa N, Morimoto T, Bao B, Shioi T, Kimura T. Effects of machine-assisted cycling on exercise capacity and endothelial function in elderly patients with heart failure. Circ J. 2012;76(8):1889-94.
  84. Bao B, Ozasa N, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Natsuaki M, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T. β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction. Cardiovasc Interv Ther. 2012 Oct [Epub ahead of print]
  85. Shiomi H, Nakagawa Y, Morimoto T, Furukawa Y, Nakano A, Shirai S, Taniguchi R, Yamaji K, Nagao K, Suyama T, Mitsuoka H, Araki M, Takashima H, Mizoguchi T, Eisawa H, Sugiyama S, Kimura T; CREDO-Kyoto AMI investigators. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study. BMJ. 2012 May 23;344.
  86. Tokushige A, Shiomi H (equally contribution), Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Ehara N, Inada T, Kaburagi S, Hamasaki S, Tei C, Nakashima H, Ogawa H, Tatami R, Suwa S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; on behalf of the CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Incidence and Outcome of Surgical Procedures after Coronary Bare-Metal and Drug-Eluting Stent Implantation: A Report From the CREDO-Kyoto PCI/CABG Registry Cohort-2. Circ Cardiovasc Interv 2012 Apr;5(2):237-46
  87. Shiomi H, Morimoto T, Hayano M, Furukawa Y, Nakagawa Y, Tazaki J, Imai M, Yamaji K, Tada T, Natsuaki M, Saijo S, Funakoshi S, Nagao K, Hanazawa K, Ehara N, Kadota K, Iwabuchi M, Shizuta S, Abe M, Sakata R, Okabayashi H, Hanyu M, Yamazaki F, Shimamoto M, Nishiwaki N, Imoto Y, Komiya T, Horie M, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2012 Oct 1;110(7):924-32.
  88. Tokushige A, Shiomi H (equally contribution), Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Hamasaki S, Tei C, Nakashima H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T. Influence of initial acute myocardial infarction presentation on the outcome of surgical procedures after coronary stent implantation: a report from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Cardiovasc Interv Ther. 2012 Sep 27. [Epub ahead of print]
  89. Kimura T, Morimoto T, Natsuaki M, Shiomi H, Igarashi K, Kadota K, Tanabe K, Morino Y, Akasaka T, Takatsu Y, Nishikawa H, Yamamoto Y, Nakagawa Y, Hayashi Y, Iwabuchi M, Umeda H, Kawai K, Okada H, Kimura K, Simonton CA, Kozuma K; RESET Investigators. Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET). Circulation. 2012 Sep 4;126(10):1225-36. Epub 2012 Jul 23.
  90. Ozasa N, Morimoto T, Bao B, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tazaki J, Natsuaki M, Kimura T; on behalf of the CREDO-Kyoto registry investigators. β-blocker use in patients after percutaneous coronary interventions: One size fits all? Worse outcomes in patients without myocardial infarction or heart failure. Int J Cardiol. 2012 [Epub ahead of print]
  91. Aihara K, Handa T, Nagai S, Tanizawa K, Ikezoe K, Watanabe K, Chihara Y, Harada Y, Yoshimura C, Oga T, Ozasa N, Uno K, Chin K, Mishima M. Impaired endothelium-dependent vasodilator response in patients with pulmonary fibrosis. Respir Med. 2013 Feb;107(2):269-75.
  92. Ozasa N, Morimoto T, Bao B, Shioi T, Kimura T. Effects of machine-assisted cycling on exercise capacity and endothelial function in elderly patients with heart failure. Circ J. 2012;76(8):1889-94.
  93. Imai S, Fukui M, Ozasa N, Ozeki T, Kurokawa M, Komatsu T, Kajiyama S. Eating vegetables before carbohydrates improves postprandial glucose excursions. Diabet Med. 2013 Mar;30(3):370-2.
  94. Bao B, Ozasa N, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Natsuaki M, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T. β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction. Cardiovasc Interv Ther. 2012 Oct 11. [Epub ahead of print]
<< 2011年｜ 業績リストTOP ｜2013年 >>
ページの先頭へ